AIM
ZSAN

Acrospire Investment Management’s Zosano Pharma Corporation ZSAN Stock Holding History

Acrospire Investment Management’s Portfolio ZSAN Stock Details ZSAN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-2
Closed -$2K – 1673
2017
Q2 		$2K Buy
+2
New +$2.06K ﹤0.01% 2071

Other funds holding ZSAN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LOAMU
Lombard Odier Asset Management (USA) New York $957M AUM 35.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ECM
Endurant Capital Management San Mateo, California $17.4M AUM 7.38% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
NC
Nexthera Capital New York $120M AUM 10.01% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JMPWA
JP Morgan Private Wealth Advisors San Francisco, California $35B AUM 24.26% 1-Year Est. Return

Acrospire Investment Management's ZSAN Position: Q3 2017 in Review

Acrospire Investment Management sold out of Zosano Pharma Corporation (ZSAN) in Q3 2017, closing a stake of 2 shares — an estimated $2K sold.

Acrospire Investment Management first reported a position in ZSAN in Q2 2017 and held it in 1 quarter. The position peaked at $2K in Q2 2017. 22 funds tracked by Wall St. Rank hold ZSAN as of Q3 2017.

  • Acrospire Investment Management reported no remaining Zosano Pharma Corporation position as of Q3 2017 after selling out during the quarter.
  • Acrospire Investment Management sold 2 Zosano Pharma Corporation shares in Q3 2017, an estimated $2K.
  • Acrospire Investment Management first reported a position in Zosano Pharma Corporation in Q2 2017 and held it in 1 quarter.
  • Acrospire Investment Management's Zosano Pharma Corporation position peaked at $2K in Q2 2017.
  • 22 funds tracked by Wall St. Rank held Zosano Pharma Corporation as of Q3 2017.

Based on Acrospire Investment Management's 13F filing for Q3 2017, filed 26 Oct 2017.